Some research suggests that GLP-1 drugs may raise the risk of a rare eye disease that causes full or partial vision loss.
Related stories
Home sellers cut asking prices on 3,000 properties a day
Evercore appoints co-presidents as it sets up CEO succession contest
Macron faces political firestorm after riots
Trump to begin transforming historic golf course despite court order
US army chief in Asia calls for show of enhanced military muscle
Microsoft pulls out of UK's largest AI data centre